CDK5 suppresses the metastasis of gastric cancer cells by interacting with and regulating PP2A

Several previous studies have demonstrated that cyclin-dependent kinase (CDK)-5 expression serves an important role in promoting the development of malignant tumours. We have previously reported that CDK5 suppresses gastric tumourigenesis. The aim of the present study was to investigate the mechanistic basis of CDK5. The results of immunoprecipitation and western blot analysis demonstrated that CDK5 could interact with serine/threonine-protein phosphatase 2A (PP2A). The use of an inhibitor of PP2A in CDK5-overexpressing gastric cancer (GC) cell lines antagonized CDK5-mediated suppression in GC cells. Further analysis revealed that PP2A expression was downregulated in GC and patients with low levels of PP2A had worse survival outcomes than those with high levels of PP2A (P=0.035). Therefore, the present study provided a novel mechanism for CDK5-mediated tumour suppression, suggesting that CDK5 may be an attractive target for future therapeutic strategies for treating GC. In addition, low levels of PP2A may indicate a tendency for poor prognosis in patients with GC.